BRAF V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximab

BRAF V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximab

This report describes a case of BRAF V600E-mutated colorectal cancer with CNS metastases in which treatment with encorafenib, binimetinib and cetuximab was effective. There is limited information on the ability of encorafenib, binimetinib and cetuximab to enter the CNS.The patient was a 53-year-old...

Full description

Saved in:
Bibliographic Details
Main Authors: Toru Imai, Hirokazu Shoji, Hidekazu Hirano, Kunihito Matsuguma, Takahito Awatsu, Toshiharu Hirose, Natsuko Okita, Atsuo Takashima, Ken Kato
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:CNS Oncology
Subjects:
binimetinib
BRAF V600E
central nervous system
cetuximab
colorectal cancer
encorafenib
Online Access:https://www.tandfonline.com/doi/10.1080/20450907.2024.2347824
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/20450907.2024.2347824

Similar Items